Stockchase Opinions

Mike S. Newton, CIM FCSI PowerShares Bio&Genome ETF PBE-N PAST TOP PICK Jan 31, 2011

(A Top Pick Feb 2/10. Up 19.34%.) Bio & Genome ETF. For 10 years biotech has been doing nothing but tech has been dong lots. Expects there will be a rediscovery of the space. Safe way to play the pharmacy space.
$21.210

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
This is a way of getting into biotech without having to invest in a single company.
PAST TOP PICK
(A Top Pick Feb 25/06. Down 6%.) A long-term hold. This is a basket of biotech shares.
PAST TOP PICK
(A Top Pick Feb 23/06. Down 16%.) When the market gets nervous, speculative stocks get hit. A long-term holding because it is a basket of biotech companies. Over time, it should give investors a good long term return.
BUY
This is a basket approach to biotechs and should be considered as a long-term hold. Good price.
TOP PICK
Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.
PAST TOP PICK
(A Top Pick Feb 2/10. Up 14.99%.) Still likes. Thinks its time is due.